Skip to Content

Oncolix Inc

Rating as of

Company Profile

Business Description

Oncolix Inc is a clinical-stage biopharmaceutical company, which engages in the development of medical therapies for the treatment of various cancers including ovarian, breast, uterine, and prostate. It is developing Prolanta, a biological drug that is in Phase I clinical trial for the treatment of ovarian cancer.

Contact
14405 Walters Road, Suite 780
Houston, TX, 77014
T +1 281 402-3167
Sector Healthcare
Industry Biotechnology
Most Recent Earnings Sep 30, 2018
Fiscal Year End Dec 31, 2018
Stock Type Slow Growth
Employees 2